文献速递妇产影像儿科影像US

产前检出先天性畸形中的全基因组测序:临床环境下的前瞻性队列研究

Whole-genome sequencing in prenatally detected congenital malformations: prospective cohort study in clinical setting.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-04-14

这项前瞻性研究对50例产前超声检出先天性畸形、且已排除染色体三体与致病性拷贝数变异的妊娠,行胎儿-父母三人全基因组测序,26%(13/50)获分子诊断,另有2例携带意义未明但可能临床相关的变异,合计30%(15/50);骨骼畸形诊断率44%(4/9)、多系统畸形43%(3/7)、中枢神经系统畸形33%(5/15)、胸部畸形10%(1/10)。

要点

  • 产前畸形且三体与致病性拷贝数变异阴性者,三人全基因组测序分子诊断率为26%(13/50)。
  • 各表型诊断率:骨骼畸形4/9(44%)、多系统畸形3/7(43%)、中枢神经系统畸形5/15(33%)、胸部畸形1/10(10%)。
  • 另2例为意义未明但可能临床相关的变异,合计检出致病或可能临床相关变异15/50(30%)。

核心结论

  • 产前检出的先天性畸形中,临床全基因组测序的诊断率为26%,全基因组测序可为胎儿结构异常的诊断带来益处。
  • 研究强调全基因组测序可提供临床相关信息,解释胎儿畸形的潜在病因,有助于判断该病的具体预后并估计再发风险,遗传诊断还可为未来妊娠提供更多生育选择。

研究设计与样本

  • 前瞻性研究,纳入50例因不同先天性畸形转诊至三级中心行产前诊断的妊娠,均经胎儿-父母三人全基因组测序分析。
  • 纳入条件为产前超声检出孤立或多发畸形后接受进一步检查的父母;排除孤立性颈项透明层增厚、配子捐赠或多胎妊娠的病例。
  • 全基因组测序采用Illumina公司30×无聚合酶链反应短读长测序,分析单核苷酸变异、插入与缺失、结构变异、短串联重复序列,以及SMN1与SMN2基因的拷贝数。

诊断标准与关键数值

  • 分子诊断在13/50(26%)病例中达成;12个基因中检出致病序列变异:FGFR3(n=2)、ACTA1(n=1)、CDH2(n=1)、COL1A2(n=1)、DHCR7(n=1)、EYA1(n=1)、FBXO11(n=1)、FRAS1(n=1)、L1CAM(n=1)、OFD1(n=1)、PDHA1(n=1)、SOX9(n=1)。
  • 按表型分组的诊断率:骨骼畸形4/9(44%)、多系统畸形3/7(43%)、中枢神经系统畸形5/15(33%)、胸部畸形1/10(10%)。
  • 另有2例携带按美国医学遗传学与基因组学学会指南评估为意义未明的变异,但被视为可能临床相关;总体检出致病或可能临床相关变异15/50(30%)。

局限性

  • 作者指出,本队列在行全基因组测序前已排除致病性染色体异常;染色体异常是产前检出先天性畸形的已知病因,未来若以全基因组测序作为一线诊断检测并涵盖染色体异常评估,检出率可能超过本研究的诊断率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the diagnostic yield of trio whole-genome sequencing (WGS) in fetuses with various congenital malformations referred to a tertiary center for prenatal diagnosis.

METHODS: In this prospective study, 50 pregnancies with different congenital malformations, negative for trisomies and causative copy-number variants, were analyzed further with fetal-parental trio WGS analysis. Parents were eligible for inclusion if they accepted further investigation following the detection of isolated or multiple malformations on prenatal ultrasound. Cases with isolated increased nuchal translucency, gamete donation or multiple pregnancy were excluded. WGS with the Illumina Inc. 30× polymerase-chain-reaction-free short-read sequencing included analysis of single-nucleotide variants, insertions and deletions, structural variants, short tandem repeats and copy-number identification of SMN1 and SMN2 genes.

RESULTS: A molecular diagnosis was achieved in 13/50 (26%) cases. Causative sequence variants were identified in 12 genes: FGFR3 (n = 2), ACTA1 (n = 1), CDH2 (n = 1), COL1A2 (n = 1), DHCR7 (n = 1), EYA1 (n = 1), FBXO11 (n = 1), FRAS1 (n = 1), L1CAM (n = 1), OFD1 (n = 1), PDHA1 (n = 1) and SOX9 (n = 1). The phenotypes of the cases were divided into different groups, with the following diagnostic yields: skeletal malformation (4/9 (44%)), multisystem malformation (3/7 (43%)), central nervous system malformation (5/15 (33%)) and thoracic malformation (1/10 (10%)). Additionally, two cases carried variants that were considered potentially clinically relevant, even though they were assessed as variants of uncertain significance, according to the guidelines provided by the American College of Medical Genetics and Genomics. Overall, we identified a causative or potentially clinically relevant variant in 15/50 (30%) cases.

CONCLUSIONS: We demonstrate a diagnostic yield of 26% with clinical WGS in prenatally detected congenital malformations. This study emphasizes the benefits that WGS can bring to the diagnosis of fetal structural anomalies. It is important to note that causative chromosomal aberrations were excluded from our cohort before WGS. As chromosomal aberrations are a well-known cause of prenatally detected congenital malformations, future studies using WGS as a primary diagnostic test, including assessment of chromosomal aberrations, may show that the detection rate exceeds the diagnostic yield of this study. WGS can add clinically relevant information, explaining the underlying cause of the fetal anomaly, which will provide information concerning the specific prognosis of the condition, as well as estimate the risk of recurrence. A genetic diagnosis can also provide more reproductive choice for future pregnancies. © 2024 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Westenius E, Conner P, Pettersson M, et al. Whole-genome sequencing in prenatally detected congenital malformations: prospective cohort study in clinical setting. Ultrasound Obstet Gynecol. 2024. PMID: 38268232. doi:10.1002/uog.27592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。